Evaluating Existing Gaps and Opportunities for Clinical Trial Diversity: Evidence from the United States

Oregon Convention Center 

Clinical trials have historically struggled to enroll representative patient populations, however, improvements have been made on multiple fronts. For instance, in 2016, women surpassed men in their participation in clinical trials (although the overwhelming majority of those were white women). Challenges still remain: racial and ethnic minority population groups, as well as older Americans, still have lower participation rates than would be representative. This presentation will present recent evidence collected as part of a report commissioned by the National Academies of Sciences, Engineering, and Medicine, demonstrate the economic potential of increasing clinical trial diversity in the United States, and indicate the opportunities for improving diversity through data-driven initiatives, including better information sharing, transparency and accountability.